I-lymphocytic leukemia, noma i-CLL , i- leukemia evame kakhulu kubantu abadala e-United States.
Kuthiwani nge-acute myeloid leukemia, noma i-AML?
- Uma wenza usesho olusheshayo lwewebhu, lokhu kungase kukukhohlise, ukholelwe ukuthi i-AML yi-leukemia evame kakhulu kubantu abadala. I-AML inezinombolo eziphakeme kunazo zonke zokuxilongwa ngonyaka, kodwa lesi sinani sibonisa umnikelo omkhulu ovela ezinganeni-i-AML yi- leukemia yesibili ejwayelekile kunazo zonke ezinganeni, futhi i-leukemia iyinomdlavuza evamile kakhulu ebuntwaneni .
- I-AML yi -leukemia ejwayelekile kakhulu e-adults, okungase ibe enye iphuzu lokudideka. Ngokubhekisela ku-leukemia, amagama anzima futhi ahlala njalo anezincazelo ezihlukile kunalokho azishoyo, zithi, uma ukhuluma nge-bronchitis enamandla ne-bronchitis engapheli. I-leukemia eqondile ibhekisela ekuthambekeni kokuqhubekela phambili ngokushesha, kuyilapho isifo esingapheli sibhekisela ku-leukemia esabhekwa ngokomlando njengendlela yokulimala okukhula kancane umuntu angase ahlale nayo iminyaka. Namuhla, i-leukemia engapheli iyaziwa ngokuhlukahluka kakhulu, ngezikhathi zokuphila ezivela eminyakeni engaba ngu-2 kuya kwengu-20 kusukela ngesikhathi sokuxilongwa.
Phakathi kwabantu abadala, izinhlobo ezivame kakhulu ze-leukemia yi-CLL (amaphesenti angu-37) ne-AML (amaphesenti angu-31). ZONKE zivame kakhulu kule minyaka engu-0 kuya ku-19, zibalwa ngamaphesenti angama-75 wamacala kulelo qembu.
Kulinganiselwa ngo-2016-2017
Abantu abangaba ngu-62.130 (bonke ubudala) bayothola ukuthi bane-leukemia, ngokusho kwe-American Cancer Society.
Nansi ukuphazamiseka ngohlobo (bonke ubudala):
I-Acute Myeloid Leukemia: 21,380
I-Lymphocytic Leukemia: 20,110
I-Chronic Myeloid Leukemia: 6 660
I-Lucphocytic Acute Leukemia: 5 970
Okunye i-Leukemia: 5 910
Imininingwane ye-CLL
I-CLL ibhekwa njengesibonakaliso esihlukile sesifo esifanayo ne-lymphocytic lymphoma encane, noma i-SLL - enye yezinhlanzi ezikhula kancane kancane ezingenayo i-Hodgkin.
Umlando womndeni ufanelekile ku-CLL; abazali, izingane zakubo, noma izingane zabantu abathintekayo abane-CLL banezingozi ezingaphezu kokuphindwe kabili zokuzikhulisa ngokwabo.
Nanka amanye amaqiniso avela eMelika Cancer Society:
- Cishe amaphesenti angu-25 azo zonke izimo ezintsha ze-leukemia yi-CLL
- Isilinganiso seengozi yokuphila se-CLL singaba ngu-1 ngo-200
- Ingozi ye-CLL ingaphezu kwamadoda kunabesifazane
- Isilinganiso seminyaka esitholakalayo siyiminyaka engaba ngu-71
- I-CLL ayidlangalaleni engaphansi kweminyaka engama-40, futhi engavamile kakhulu ezinganeni.
Izinkomba mayelana Nesizathu
Ngokusho kwe-American Cancer Society, abacwaningi bakholelwa ukuthi i-CLL iqala lapho i- B-lymphocytes - uhlobo lwegciwane legazi elimhlophe elingavuthwa ukwenza ama-antibodies - liqhubeke lihlukanisa lingagciniwe futhi lingavinjelwe ngemuva kokuhlangana nokuqaphela i-antigen yangaphandle . Okushiwo ukuthi lokhu kwenzeka kanjani kanye nemininingwane yazo zonke izinyathelo ezihilelekile akukaziwa, kodwa ezinye zezici ze-CLL ezenziwe ngezakhi zofuzo zichazwe futhi ziqala ukuqonda kangcono.
Mayelana no-17p ukususwa CLL
Ukukhishwa kwe-CLP 17p kubizwe ngokuthi i-chromosome ethize, i-chromosome engu-17, ilahlekile - futhi, isikhathi esiningi, kanye nayo ihamba ngegesi ebalulekile ebizwa ngokuthi i-p53 elawula ukupheka kwe-apoptosis, noma ukufa kwe-cell program.
Ukususwa kwe-17p kutholakala kumaphesenti angaba ngu-3 kuya kwangu-10 abantu abane-CLL, jikelele. 17p ukususa CLL uhlobo lwe-CLL oluyinkimbinkimbi yokwelapha; Abantu abane-CLP yokukhishwa kwe-17p kunzima ukuphatha nge-chemotherapy evamile. Inani eliphakathi, eliphakathi noma eliphakathi, lokuhlala esikhathini esingaphansi kweminyaka emithathu.
Ukuze uthole okwengeziwe kulokhu, bheka isigaba 'CLL nokukhishwa kwe-17p' kusihloko esixhunyiwe.
Ukuze uthole ulwazi oluthe xaxa ku-CLL, bheka isihloko sika-Karen Raymaakers .
> Imithombo:
> I-Leukemia neLymphoma Society. Amaqiniso nezibalo. Ifinyelele ngo-September 2017.
> I-American Cancer Society. I-Leukemia - I-Lymphocytic Yangapheli. Ifinyelele ngo-September 2017.
> Iqiniso le-Cancer Facts & Figures, 2017 . I-American Cancer Society. 2017. Kufinyelelwe ngo-September 2017.